Treatment-resistant depression complicates care, defying standard treatments, but new therapies are on the horizon, offering hope for more effective treatment options.

Q4 2024 Earnings Call Transcript February 25, 2025 LivaNova PLC beats earnings expectations. Reported EPS is $0.81, ...

In the UK, around 10% of the general population experiences insomnia symptoms, which contributes to their poor mental health, ...

Ketamine is an old anesthesia drug with psychedelic qualities, and it has been getting a lot of attention for its ability to ...

Fourth quarter 2024 net sales of Qelbree® increased 60% to $74.4 million, compared to the same period in 2023. Full year 2024 net sales of Qelbree increased 72% to $241.3 million, compared to full yea ...

For roughly 5% of adults, seasonal change comes with more than discomfort or melancholy. Seasonal affective disorder is a ...

Vitamin D deficiency (VDD) is independently associated with increased depression risk in patients with chronic kidney disease ...

A UVA Health study, conducted with Flo, a women’s health app, finds more than half of the women aged 30 to 35 who ...

Objective To assess the prevalence of depression and its associated factors among individuals with disabilities. Design Cross-sectional study. Setting Community-based study conducted in Ilam ...